Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses

Journal: Nature Communications

Published: 2020-02-07

DOI: 10.1038/s41467-020-14579-4

Affiliations: 3

Authors: 18

Go to article
Institutions Share
NIH NIAID Vaccine Research Center (VRC), United States of America (USA) 0.83
Cancer Research Technology Program (CRTP), FNLCR, United States of America (USA) 0.11
Biomedical Research Center, Qatar University, Qatar 0.06